Innovation in Quantitative Medicine Summit

The Duke-Margolis Institute for Health Policy and the U.S. Food and Drug Administration's Quantitative Medicine Center of Excellence will co-convene a virtual workshop on September 1, 2026, to inform the establishment of the Quantitative Medicine Innovation Network (QMIN). The QMIN will bring together academic institutions, industry sponsors, contract research organizations, regulators, and patient advocates in a sustained, cross-sector collaboration to advance the science and regulatory application of quantitative medicine with the goal of fundamentally transforming drug development and clinical care.

All are welcome to attend.